| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 36,185 | 47,380 | 31,548 | 22,894 | | Cost of Revenue | 32,738 | 40,158 | 26,718 | 23,298 | | | Gross Profit | 3,447 | 7,222 | 4,830 | (404) | | | Operating Expenses | | Research Development | 443 | 580 | 492 | 210 | | Selling General and Administrative | 4,902 | 4,539 | 4,212 | 2,167 | | Non Recurring |
-
|
-
|
-
| (3,495) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,898) | 2,103 | 126 | 714 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (29) | 711 | (635) | (164) | | Earnings Before Interest And Taxes | (1,927) | 2,814 | (509) | 550 | | Interest Expense | 1,282 | 1,040 | 864 | 909 | | Income Before Tax | (3,209) | 1,774 | (1,373) | (359) | | Income Tax Expense | (4) | (195) |
-
| (282) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (3,205) | 1,969 | (1,373) | (77) | | | Non-recurring Events | | Discontinued Operations | (69) | (810) | 1,056 | (1,756) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,274) | 1,159 | (317) | (1,833) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($3,274) | $1,159 | ($317) | ($1,833) |
|
0.14% Nasdaq 
0.07 (1.44%) 
Income Statement
